logo

Mediwound Ltd. (MDWD)



Trade MDWD now with
  Date
  Headline
7/11/2022 7:14:59 AM MediWound Announces Positive Initial Data From U.S. Phase I/II Study Of MW005 For Basal Cell Carcinoma
7/7/2022 7:07:49 AM MediWound Announces Positive Results From Phase 2 Pharmacology Study Of EscharEx
3/17/2022 7:24:40 AM MediWound Q4 Loss Per Share $0.50 Vs Loss $0.34 Last Year
1/24/2022 6:06:33 AM MediWound Announces Positive Topline Results From U.S. Phase 2 Trial Of EscharEx For Debridement Of Chronic Wounds